475 related articles for article (PubMed ID: 25510130)
1. [Initial antiretroviral therapy in HIV-infected patients].
Cormier H; Hoen B
Rev Prat; 2014 Oct; 64(8):1079-85. PubMed ID: 25510130
[TBL] [Abstract][Full Text] [Related]
2. French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.
Hoen B; Bonnet F; Delaugerre C; Delobel P; Goujard C; L'Hénaff M; Persiaux R; Rey D; Rouzioux C; Taburet AM; Morlat P;
J Int AIDS Soc; 2014; 17(1):19034. PubMed ID: 24942364
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients.
D'Abbraccio M; Busto A; De Marco M; Figoni M; Maddaloni A; Abrescia N
AIDS Rev; 2015; 17(3):171-85. PubMed ID: 26450805
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
5. Advances in antiretroviral therapy.
Arribas JR; Eron J
Curr Opin HIV AIDS; 2013 Jul; 8(4):341-9. PubMed ID: 23666392
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
Thompson MA; Aberg JA; Hoy JF; Telenti A; Benson C; Cahn P; Eron JJ; Günthard HF; Hammer SM; Reiss P; Richman DD; Rizzardini G; Thomas DL; Jacobsen DM; Volberding PA
JAMA; 2012 Jul; 308(4):387-402. PubMed ID: 22820792
[TBL] [Abstract][Full Text] [Related]
7. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017).
AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan
Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):435-445. PubMed ID: 28579016
[TBL] [Abstract][Full Text] [Related]
8. Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.
Burgos J; Crespo M; Falcó V; Curran A; Navarro J; Imaz A; Domingo P; Podzamczer D; Mateo MG; Villar S; Van den Eynde E; Ribera E; Pahissa A
J Antimicrob Chemother; 2012 Oct; 67(10):2479-86. PubMed ID: 22729925
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
DeJesus E; Saleh S; Cheng S; van der Mey D; Becker C; Frey R; Unger S; Mueck W
Pulm Circ; 2019; 9(2):2045894019848644. PubMed ID: 30997864
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Aberg JA; Eron JJ; Hoy JF; Telenti A; Benson CA; Burger DM; Cahn P; Gallant JE; Glesby MJ; Reiss P; Saag MS; Thomas DL; Jacobsen DM; Volberding PA;
JAMA; 2014 Jul 23-30; 312(4):410-25. PubMed ID: 25038359
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States.
Brogan AJ; Talbird SE; Cohen C
Value Health; 2011; 14(5):657-64. PubMed ID: 21839403
[TBL] [Abstract][Full Text] [Related]
12. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.
Palella FJ; Fisher M; Tebas P; Gazzard B; Ruane P; Van Lunzen J; Shamblaw D; Flamm J; Ebrahimi R; Porter D; White K; Hindman J; Elbert E; De-Oertel S; Fralich T
AIDS; 2014 Jan; 28(3):335-44. PubMed ID: 24670520
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic enhancement in HIV antiretroviral therapy: a comparison of ritonavir and cobicistat.
Renjifo B; van Wyk J; Salem AH; Bow D; Ng J; Norton M
AIDS Rev; 2015; 17(1):37-46. PubMed ID: 25586481
[TBL] [Abstract][Full Text] [Related]
14. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
Hill A; Sawyer W
HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663
[TBL] [Abstract][Full Text] [Related]
15. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
Llibre JM; Clotet B
AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of antiretroviral drugs].
Ribera E; Tuset M; Martín M; del Cacho E
Enferm Infecc Microbiol Clin; 2011 May; 29(5):362-91. PubMed ID: 21531048
[TBL] [Abstract][Full Text] [Related]
17. Similar efficacy and tolerability of atazanavir compared with atazanavir/ritonavir, each with abacavir/lamivudine after initial suppression with abacavir/lamivudine plus ritonavir-boosted atazanavir in HIV-infected patients.
Squires KE; Young B; Dejesus E; Bellos N; Murphy D; Zhao HH; Patel LG; Ross LL; Wannamaker PG; Shaefer MS;
AIDS; 2010 Aug; 24(13):2019-27. PubMed ID: 20613461
[TBL] [Abstract][Full Text] [Related]
18. Cost considerations in the current antiretroviral era.
Eaton EF; Tamhane A; Saag M; Mugavero MJ; Kilgore ML
AIDS; 2016 Sep; 30(14):2115-9. PubMed ID: 27088319
[TBL] [Abstract][Full Text] [Related]
19. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
Raffi F; Jaeger H; Quiros-Roldan E; Albrecht H; Belonosova E; Gatell JM; Baril JG; Domingo P; Brennan C; Almond S; Min S;
Lancet Infect Dis; 2013 Nov; 13(11):927-35. PubMed ID: 24074642
[TBL] [Abstract][Full Text] [Related]
20. Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
Di Biagio A; Prinapori R; Giannarelli D; Maggiolo F; Di Giambenedetto S; Borghi V; Penco G; Cicconi P; Francisci D; Sterrantino G; Zoncada A; Monno L; Capetti A; Giacometti A;
J Antimicrob Chemother; 2013 Jan; 68(1):200-5. PubMed ID: 22915463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
